|
|
|
UNITED STATES
|
||
SECURITIES AND EXCHANGE COMMISSION
|
||
Washington, D.C. 20549
|
||
FORM 10-K
|
||
þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||
For the fiscal year ended January 31, 2018
|
||
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||
For the transition period from to
|
||
Commission File Number: 001-07982
|
||
RAVEN INDUSTRIES, INC.
|
||
(Exact name of registrant as specified in its charter)
|
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
|
þ
|
Yes
|
o
|
No
|
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
|
o
|
Yes
|
þ
|
No
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
|
þ
|
Yes
|
o
|
No
|
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
|
þ
|
Yes
|
o
|
No
|
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
|
þ
|
|
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
|
o
|
Yes
|
þ
|
No
|
The aggregate market value of the registrant's common stock held by non-affiliates at July 31, 2017 was approximately $1,231,707,927. The aggregate market value was computed by reference to the closing price as reported on the NASDAQ Global Select Market, $34.40, on July 31, 2017, which was as of the last business day of the registrant's most recently completed second fiscal quarter. The number of shares outstanding on March 16, 2018 was 35,796,857.
|
||||
DOCUMENTS INCORPORATED BY REFERENCE
|
||||
The definitive proxy statement relating to the registrant's Annual Meeting of Shareholders, to be held May 22, 2018, is incorporated by reference into Part III to the extent described therein.
|
||||
|
|
|
|
|
ITEM 1A.
|
RISK FACTORS
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
ITEM 2.
|
PROPERTIES
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
PART II
|
|
|
|
ITEM 5.
|
MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
|
|
Years Ended January 31,
|
|
5-Year
|
|||||||||||||||||||||||
Company / Index
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
|
2018
|
|
CAGR(a)
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Raven Industries, Inc.
|
|
$
|
100.00
|
|
|
$
|
141.12
|
|
|
$
|
82.29
|
|
|
$
|
59.29
|
|
|
$
|
101.55
|
|
|
$
|
158.77
|
|
|
9.7
|
%
|
S&P 1500 Industrial Machinery Index
|
|
100.00
|
|
|
125.99
|
|
|
130.62
|
|
|
119.14
|
|
|
170.46
|
|
|
223.32
|
|
|
17.4
|
%
|
||||||
Russell 2000 Index
|
|
100.00
|
|
|
127.03
|
|
|
132.63
|
|
|
119.47
|
|
|
159.53
|
|
|
186.94
|
|
|
13.3
|
%
|
||||||
S&P Small Cap 600 Index
|
|
100.00
|
|
|
128.44
|
|
|
136.34
|
|
|
129.95
|
|
|
174.58
|
|
|
203.49
|
|
|
15.3
|
%
|
||||||
(a) compound annual growth rate (CAGR)
|
|
|
|
|
|
|
|
|
|
|
|
|
ITEM 6.
|
SELECTED FINANCIAL DATA
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
•
|
Executive Summary
|
•
|
Results of Operations - Segment Analysis
|
•
|
Liquidity and Capital Resources
|
•
|
Off-Balance Sheet Arrangements and Contractual Obligations
|
•
|
Critical Accounting Policies and Estimates
|
•
|
Accounting Pronouncements
|
•
|
Consolidated net sales, gross margin, operating income, operating margin, net income, and diluted earnings per share
|
•
|
Cash flow from operations and shareholder returns
|
•
|
Return on sales, average assets, and average equity
|
•
|
Segment net sales, gross profit, gross margin, operating margin, and operating income. At the segment level, operating income does not include an allocation of general and administrative expenses.
|
•
|
Consolidated net sales excluding contract manufacturing sales (adjusted sales)
|
•
|
Segment net sales excluding contract manufacturing sales (adjusted sales)
|
•
|
Segment operating income excluding Vista charges (adjusted operating income)
|
•
|
Consolidated operating income excluding Vista charges (consolidated adjusted operating income)
|
•
|
Net income excluding Vista charges (adjusted net income)
|
•
|
Intentionally serve a set of diversified market segments with attractive near- and long-term growth prospects;
|
•
|
Consistently manage a pipeline of growth initiatives within our market segments;
|
•
|
Aggressively compete on quality, service, innovation, and peak performance;
|
•
|
Hold ourselves accountable for continuous improvement;
|
•
|
Value our balance sheet as a source of strength and stability with which to pursue strategic acquisitions; and
|
•
|
Make corporate responsibility a top priority.
|
|
|
For the year ended January 31,
|
||
(dollars in thousands)
|
|
2016
|
||
Applied Technology
|
|
|
||
Reported net sales
|
|
$
|
92,599
|
|
Less: Contract manufacturing sales
|
|
546
|
|
|
Applied Technology net sales, excluding
contract manufacturing sales
|
|
$
|
92,053
|
|
|
|
|
||
Aerostar
|
|
|
||
Reported net sales
|
|
$
|
36,368
|
|
Less: Contract manufacturing sales
|
|
4,701
|
|
|
Aerostar net sales, excluding contract
manufacturing sales
|
|
$
|
31,667
|
|
|
|
|
||
Consolidated Raven
|
|
|
||
Reported net sales
|
|
$
|
258,229
|
|
Less: Contract manufacturing sales
|
|
5,247
|
|
|
Consolidated net sales, excluding contract
manufacturing sales
|
|
$
|
252,982
|
|
|
|
For the years ended January 31,
|
||||||||||||||||
(dollars in thousands)
|
|
2018
|
|
% change
|
|
2017
|
|
% change
|
|
2016
|
||||||||
Consolidated Raven
|
|
|
|
|
|
|
|
|
|
|
||||||||
Reported net income attributable to Raven Industries, Inc.
|
|
$
|
41,022
|
|
|
103.2
|
%
|
|
$
|
20,191
|
|
|
322.8
|
%
|
|
$
|
4,776
|
|
Plus:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Goodwill impairment loss
|
|
—
|
|
|
|
|
—
|
|
|
|
|
11,497
|
|
|||||
Long-lived asset impairment loss
|
|
—
|
|
|
|
|
—
|
|
|
|
|
3,813
|
|
|||||
Pre-contract costs written off
|
|
—
|
|
|
|
|
—
|
|
|
|
|
2,933
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
Less:
|
|
|
|
|
|
|
|
|
|
|
||||||||
Acquisition-related contingent liability benefit
|
|
—
|
|
|
|
|
—
|
|
|
|
|
2,273
|
|
|||||
Net tax benefit on adjustments
|
|
—
|
|
|
|
|
—
|
|
|
|
|
5,693
|
|
|||||
Adjusted net income attributable to Raven
Industries, Inc.
|
|
$
|
41,022
|
|
|
103.2
|
%
|
|
$
|
20,191
|
|
|
34.1
|
%
|
|
$
|
15,053
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Adjusted net income per common share:
|
|
|
|
|
|
|
|
|
|
|
||||||||
─ Basic
|
|
$
|
1.14
|
|
|
103.6
|
%
|
|
$
|
0.56
|
|
|
40.0
|
%
|
|
$
|
0.40
|
|
─ Diluted
|
|
$
|
1.13
|
|
|
101.8
|
%
|
|
$
|
0.56
|
|
|
40.0
|
%
|
|
$
|
0.40
|
|
|
|
For the years ended January 31,
|
||||||||||||||||
(dollars in thousands)
|
|
2018
|
|
% change
|
|
2017
|
|
% change
|
|
2016
|
||||||||
Net sales
|
|
$
|
124,688
|
|
|
18.5
|
%
|
|
$
|
105,217
|
|
|
13.6
|
%
|
|
$
|
92,599
|
|
Gross profit
|
|
54,682
|
|
|
25.8
|
%
|
|
43,476
|
|
|
28.0
|
%
|
|
33,969
|
|
|||
Gross margin
|
|
43.9
|
%
|
|
|
|
41.3
|
%
|
|
|
|
36.7
|
%
|
|||||
Operating expense
|
|
$
|
23,166
|
|
|
37.6
|
%
|
|
$
|
16,833
|
|
|
7.6
|
%
|
|
$
|
15,650
|
|
Operating expense as % of sales
|
|
18.6
|
%
|
|
|
|
16.0
|
%
|
|
|
|
16.9
|
%
|
|||||
Long-lived asset impairment loss
|
|
259
|
|
|
|
|
$
|
—
|
|
|
|
|
—
|
|
||||
Operating income(a)
|
|
$
|
31,257
|
|
|
17.3
|
%
|
|
$
|
26,643
|
|
|
45.4
|
%
|
|
18,319
|
|
|
Operating margin
|
|
25.1
|
%
|
|
|
|
25.3
|
%
|
|
|
|
19.8
|
%
|
|||||
Applied Technology net sales,
excluding contract manufacturing
sales(b)
|
|
NMF
|
|
NMF
|
|
NMF
|
|
|
NMF
|
|
|
$
|
92,053
|
|
||||
(a) At the segment level, operating income does not include an allocation of general and administrative expenses.
|
||||||||||||||||||
(b) Reduction of contract manufacturing was largely completed in fiscal 2016; measure is not meaningful (NMF) for comparisons in subsequent fiscal periods.
|
•
|
Market conditions. Conditions in the agriculture market remain subdued; however, Applied Technology's marketplace strategy has capitalized on new product introductions in fiscal 2018. While OEM and aftermarket sales channel demand
|
•
|
Sales volume and selling prices. Sales in the OEM and aftermarket channels were up 32.4% and 6.3%, respectively, in fiscal 2018. Fiscal 2018 domestic sales were up 25.0% while international sales were up 1.5%. Higher sales volume, rather than an increase in selling price, was the main driver for these increases.
|
•
|
International sales. Net sales outside the U.S. accounted for 23.6% of segment sales in fiscal 2018 compared to 27.6% in fiscal 2017. International sales increased $0.4 million, or 1.5%, to $29.4 million in fiscal 2018 compared to fiscal 2017. Higher sales in Latin America and Europe, partially offset by a decrease in Canada, were the primary drivers of the increase. European revenue growth included strong growth at SBG in fiscal 2018. For the fourth quarter, international sales totaled $6.3 million, an increase of 6.2% from the prior year comparative quarter.
|
•
|
Gross margin. Gross margin increased from 41.3% in fiscal 2017 to 43.9% in fiscal 2018. Higher sales volume and lower manufacturing costs increased operating leverage and drove the increase in gross margin. Due to the existing available capacity of the manufacturing facilities, the increase in sales volume did not require a commensurate increase in costs in fiscal 2018.
|
•
|
Operating expenses. Fiscal 2018 operating expenses were 18.6% of net sales compared to 16.0% for the prior year. Throughout fiscal 2018, the division continued to invest in research and development activities to position itself for incremental new product sales and market share gains in future years.
|
•
|
Market conditions. Conditions in the agriculture market remain subdued; however, Applied Technology's marketplace strategy has capitalized on new product introductions in fiscal 2017. While OEM and aftermarket sales channel demand remains challenging, Applied Technology achieved fourth quarter and year-to-date sales growth compared to the prior year primarily due to market share gains driven by new product introductions and expanded relationships with OEM partners. These were the primary growth drivers both domestically and internationally.
|
•
|
Sales volume and selling prices. Fiscal 2017 sales increased 13.6% to $105.2 million as compared to $92.6 million in the prior fiscal year. Sales in the OEM and aftermarket channels were up 25.1% and 6.1%, respectively, in fiscal 2017. Fiscal 2017 domestic sales were up 9.9% while international sales were up 24.8%. Higher sales volume, rather than an increase in selling price, was the main driver for these increases.
|
•
|
International sales. Net sales outside the U.S. accounted for 27.6% of segment sales in fiscal 2017 compared to 25.1% in fiscal 2016. International sales increased $5.8 million, or 24.8%, to $29.0 million in fiscal 2017 compared to fiscal 2016. Higher sales in Canada and Europe were the primary drivers of the increase. European revenue growth included strong growth at SBG in fiscal 2017. For the fourth quarter, international sales totaled $5.9 million, an increase of 29.8% from the prior year comparative quarter.
|
•
|
Gross margin. Gross margin increased from 36.7% in fiscal 2016 to 41.3% in fiscal 2017. Higher sales volume and lower manufacturing costs including increased leverage of fixed manufacturing costs contributed to the higher margin. Due to the existing available capacity of the facilities, the increase in sales volume did not require a commensurate increase in costs in fiscal 2017.
|
•
|
Restructuring expenses. Fiscal 2016 results included severance and other related exit activity totaling $0.6 million. These costs were offset by completion of the St. Louis contract manufacturing exit activities which resulted in gains of $0.6 million recorded in the fiscal 2016 results. There were no impairments recorded as a result of the exit of this business. No restructuring or exit costs were incurred in the three-month period ended January 31, 2016. No restructuring or exit costs were incurred in the three-month or year-to-date period ended January 31, 2017.
|
•
|
Operating expenses. Fiscal 2017 operating expenses were 16.0% of net sales compared to 16.9% for the prior year. Operating expenses increased less than revenues due primarily to continued cost control measures and resulted in a lower percentage of sales year-over-year.
|
|
|
For the years ended January 31,
|
||||||||||||||||
(dollars in thousands)
|
|
2018
|
|
% change
|
|
2017
|
|
% change
|
|
2016
|
||||||||
Net sales
|
|
$
|
213,298
|
|
|
53.6
|
%
|
|
$
|
138,855
|
|
|
7.3
|
%
|
|
$
|
129,465
|
|
Gross profit
|
|
56,255
|
|
|
91.3
|
%
|
|
29,407
|
|
|
17.3
|
%
|
|
25,076
|
|
|||
Gross margin
|
|
26.4
|
%
|
|
|
|
21.2
|
%
|
|
|
|
19.4
|
%
|
|||||
Operating expenses
|
|
$
|
8,931
|
|
|
38.7
|
%
|
|
$
|
6,441
|
|
|
(10.3
|
)%
|
|
$
|
7,184
|
|
Operating expenses as % of sales
|
|
4.2
|
%
|
|
|
|
4.6
|
%
|
|
|
|
5.5
|
%
|
|||||
Operating income(a)
|
|
$
|
47,324
|
|
|
106.1
|
%
|
|
$
|
22,966
|
|
|
28.4
|
%
|
|
$
|
17,892
|
|
Operating margin
|
|
22.2
|
%
|
|
|
|
16.5
|
%
|
|
|
|
13.8
|
%
|
|||||
(a) At the segment level, operating income does not include an allocation of general and administrative expenses.
|
•
|
Market conditions. Engineered Films produces high-performance plastic films and sheeting for geomembrane, agricultural, construction, and industrial applications. Each of these markets had significant growth in fiscal 2018, with the geomembrane and construction markets growing most significantly. Geomembrane end-market conditions for Engineered Films exhibited significant year-over-year improvement throughout fiscal 2018. U.S. land-based rig counts have increased 34.6% from January 2017 to January 2018. Additionally, as discussed in more detail in Note 6 Acquisitions and Investments in Business and Technologies of the Notes to the Consolidated Financial Statements, Engineered Films acquired the assets of CLI in September 2017. This acquisition enhanced the division's geomembrane market position through extended service and product offerings with the addition of new design-build and installation service components. The acquisition of CLI advanced Engineered Films’ business model into a vertically-integrated, full-service solutions provider for the geomembrane market. CLI contributed $13.1 million in net sales in fiscal 2018. For fiscal 2018, sales into the geomembrane market increased 103.3% year-over-year. The growth in the construction market was driven by delivery of hurricane recovery film. Due to the unusually devastating hurricane season, delivery of hurricane recovery film during fiscal 2018 resulted in sales of $24.2 million. It has been several years since the Company received a substantial increase in demand for hurricane recovery film, and sales of such film are generally less than $2.0 million on an annual basis. For fiscal 2018, sales into the construction market increased 46.8% year-over-year.
|
•
|
Sales volume and selling prices. Primary drivers of the increase in net sales were the improved conditions within the geomembrane and industrial markets, the acquisition of CLI, and the delivery of hurricane recovery film, which added $2.3 million, $7.9 million and $15.8 million, in the fourth quarter of fiscal 2018, and $34.9 million, $13.1 million and $24.2 million, in the 2018 full fiscal year, respectively.
|
•
|
Gross margin. Fiscal 2018 gross margin was 26.4%, 5.2 percentage points higher than the prior fiscal year. During fiscal 2018 fourth quarter, the gross margin was 26.3% compared to 20.5% in the prior year fourth quarter. The increase for both periods was primarily the result of operational efficiency gains developed throughout the year and higher sales volume that improved capacity utilization and resulted in fixed cost leverage. Due to the existing available capacity of the facilities, the increase in sales volume did not require a commensurate increase in costs in fiscal 2018.
|
•
|
Operating expenses. Fiscal 2018 operating expenses, as a percentage of net sales, decreased to 4.2%, from 4.6% in the prior year. Operating expenses increased less than revenues due primarily to continued cost control measures and resulted in a lower percentage of sales year-over-year.
|
•
|
Market conditions. End-market conditions have improved in the geomembrane market in the second half of fiscal 2017 for Engineered Films. U.S. land-based rig counts have increased approximately 17.0% from January 2016 to January 2017. For fiscal 2017, sales into the geomembrane market increased 16.9% year-over-year.
|
•
|
Sales volume and selling prices. Fiscal 2017 net sales were up 7.3% to $138.9 million compared to fiscal 2016 net sales of $129.5 million. Sales volume, measured in pounds, for fiscal 2017 was up 11.4%. Primary drivers of the increase in sales volume included the improved market conditions within the geomembrane market and new sales into the industrial and geomembrane markets as a result of successfully selling capacity of the division's new production line that was commissioned in the fiscal 2017 first quarter. Average selling prices for the same period were down approximately 3.7% compared to the prior fiscal year primarily due to product mix and the competitive landscape in the geomembrane market. Fourth quarter fiscal 2017 sales volume was up 34.0% compared to fourth quarter fiscal 2016. Fourth quarter average selling prices increased 1.3% year-over-year.
|
•
|
Gross margin. Fiscal 2017 gross margin was 21.2%, 1.8 percentage points higher than the prior fiscal year. During fiscal 2017 fourth quarter, the gross margin was 20.5% compared to 15.0% in the prior year fourth quarter. The increase for both periods was primarily the result of higher sales volume. Due to the existing available capacity of the facilities, the increase in sales volume did not require a commensurate increase in costs in fiscal 2017. In addition, benefits from value engineering, reformulation efforts, pricing discipline, and favorable raw material cost developments also benefited gross margin.
|
•
|
Operating expenses. Fiscal 2017 operating expenses, as a percentage of net sales, decreased to 4.6%, from 5.5% in the prior year. Sales volume increased while selling expense decreased compared to fiscal year 2016 as a result of cost control measures and lower bad debt expense.
|
|
|
For the years ended January 31,
|
||||||||||||||||
(dollars in thousands)
|
|
2018
|
|
% change
|
|
2017
|
|
% change
|
|
2016
|
||||||||
Net sales
|
|
$
|
39,915
|
|
|
17.0
|
%
|
|
$
|
34,113
|
|
|
(6.2
|
)%
|
|
$
|
36,368
|
|
Gross profit
|
|
10,608
|
|
|
99.4
|
%
|
|
5,319
|
|
|
(32.1
|
)%
|
|
7,838
|
|
|||
Gross margin
|
|
26.6
|
%
|
|
|
|
15.6
|
%
|
|
|
|
21.6
|
%
|
|||||
Operating expenses
|
|
$
|
6,486
|
|
|
(4.5
|
%)
|
|
$
|
6,792
|
|
|
(7.2
|
)%
|
|
$
|
7,316
|
|
Operating expenses as % of sales
|
|
16.2
|
%
|
|
|
|
19.9
|
%
|
|
|
|
20.1
|
%
|
|||||
Goodwill and long-lived asset impairment loss
|
|
$
|
—
|
|
|
|
|
$
|
87
|
|
|
|
|
$
|
15,323
|
|
||
Operating (loss) income(a)
|
|
4,122
|
|
|
(364.2
|
)%
|
|
(1,560
|
)
|
|
(89.5
|
)%
|
|
(14,801
|
)
|
|||
Operating margin
|
|
10.3
|
%
|
|
|
|
(4.6
|
)%
|
|
|
|
(40.7
|
)%
|
|||||
Aerostar net sales, excluding
contract manufacturing sales(b)
|
|
NMF
|
|
NMF
|
|
NMF
|
|
|
NMF
|
|
|
$
|
31,667
|
|
||||
(a) At the segment level, operating (loss) income does not include an allocation of general and administrative expenses.
|
||||||||||||||||||
(b) Reduction of contract manufacturing was largely completed in fiscal 2016; measure is not meaningful (NMF) for comparisons in subsequent fiscal periods.
|
•
|
Market conditions. Aerostar's markets are subject to significant variability due to government spending and the timing of contract awards. Aerostar is also pioneering new markets with leading-edge applications of its stratospheric balloons and remains in active collaboration with Google on Project Loon. Project Loon is a program to provide high-speed wireless Internet accessibility and telecommunications to rural, remote, and under-served areas of the world. During fiscal 2018 Aerostar had several new contract wins further expanding the market for its stratospheric balloons.
|
•
|
Sales volume. The increase was principally driven by higher sales of stratospheric balloons and radar systems.
|
•
|
Gross margin. For fiscal 2018, gross margin increased 11.0 percentage points compared to the prior fiscal year. The improved profitability was driven by higher sales volume, and the absence of inventory write-downs, which lowered prior year results by $2.3 million.
|
•
|
Operating expenses. Operating expenses as a percentage of net sales decreased 3.7 percentage points compared to prior fiscal year. Fiscal 2018 operating expenses were $6.5 million, or 16.2% of net sales, compared to operating expenses of $6.8 million, or 19.9% of net sales in fiscal 2017.
|
•
|
Market conditions. Aerostar is experiencing delays and uncertainties regarding certain opportunities important to the division's growth strategy, and some of Aerostar's markets are subject to significant variability due to government spending and the timing of contract awards. Aerostar is pioneering new markets with leading-edge applications of its high-altitude balloons and remains in active collaboration with Google on Project Loon. Project Loon is a program to provide high-speed wireless Internet accessibility and telecommunications to rural, remote, and under-served areas of the world.
|
•
|
Sales volume. Fiscal 2017 net sales decreased $2.3 million from the prior year, a year-over-year decrease of 6.2%. The decline was principally driven by lower aerostat sales due to the timing of deliveries. This was partially offset by higher sales of stratospheric balloons for Project Loon and other customers newly established in fiscal 2017.
|
•
|
Gross margin. For fiscal 2017, gross margin decreased 6.0 percentage points compared to the prior fiscal year. Fiscal 2017 gross margin decline was primarily driven by lower sales volume and $2.3 million of inventory write-downs related to certain radar systems discussed in more detail in Note 7 Goodwill, Long-lived Assets, and Other Charges of the Notes to the Consolidated Financial Statements, offset somewhat by a $1.3 million reduction in depreciation and amortization expense due to the long-lived asset impairment charges recorded in fiscal 2016.
|
•
|
Goodwill and long-lived asset impairment loss. In fiscal 2016, Aerostar recorded a goodwill impairment loss of $11.5 million and a long-lived asset impairment loss of $3.8 million. These impairment charges were recorded in the Vista reporting unit and are described more fully in Note 7 Goodwill, Long-lived Assets, and Other Charges of the Notes to the Consolidated Financial Statements. As also described in Note 7 Goodwill, Long-lived Assets, and Other Charges, a $0.1 million long-lived asset impairment loss was recorded in fiscal 2017 on the Radar asset group. Expense control measures executed throughout fiscal year 2017 reduced operating expenses year-over-year.
|
•
|
Operating expenses. Operating expenses as a percentage of net sales was essentially flat year-over-year. Fiscal 2017 operating expenses of $6.8 million were 19.9% of net sales compared to operating expenses of $7.3 million, equivalent to 20.1% of net sales in fiscal 2016.
|
•
|
Aerostar adjusted operating income. Aerostar reported an operating loss of $1.6 million in fiscal 2017 compared to an operating loss of $14.8 million in fiscal 2016. The fiscal 2016 results were impacted by the Vista goodwill and long-lived asset impairments and associated financial impacts. Excluding these Vista related items, adjusted operating income in fiscal 2016 was $1.2 million, compared to an operating loss of $1.6 million for fiscal 2017, a decline of $2.8 million on an adjusted basis. This decline in operating income was primarily driven by lower sales volume and $2.3 million of inventory write-downs related to certain radar systems, offset somewhat by a $1.3 million reduction in depreciation and amortization expense due to the long-lived asset impairment charges recorded in fiscal 2016.
|
|
|
For the years ended January 31,
|
||||||||||
(dollars in thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
Administrative expenses
|
|
$
|
23,553
|
|
|
$
|
19,624
|
|
|
$
|
17,110
|
|
Administrative expenses as a % of sales
|
|
6.2
|
%
|
|
7.1
|
%
|
|
6.6
|
%
|
|||
Other (expense), net
|
|
$
|
(184
|
)
|
|
$
|
(560
|
)
|
|
$
|
(310
|
)
|
Effective tax rate
|
|
30.5
|
%
|
|
27.5
|
%
|
|
(18.8
|
)%
|
|
|
As of January 31,
|
||||||||||
(dollars in thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
Cash and cash equivalents
|
|
$
|
40,535
|
|
|
$
|
50,648
|
|
|
$
|
33,782
|
|
|
|
For the years ended January 31,
|
||||||||||
(dollars in thousands)
|
|
2018
|
|
2017
|
|
2016
|
||||||
Cash provided by operating activities
|
|
$
|
44,961
|
|
|
$
|
48,636
|
|
|
$
|
44,008
|
|
Cash used in investing activities
|
|
(25,675
|
)
|
|
(4,642
|
)
|
|
(11,074
|
)
|
|||
Cash used in financing activities
|
|
(29,721
|
)
|
|
(27,151
|
)
|
|
(50,684
|
)
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
|
322
|
|
|
23
|
|
|
(417
|
)
|
|||
Net increase (decrease) in cash and cash equivalents
|
|
$
|
(10,113
|
)
|
|
$
|
16,866
|
|
|
$
|
(18,167
|
)
|
(dollars in thousands)
|
|
Total
|
|
Less than
1 year
|
|
1-3
years
|
|
3-5
years
|
|
More than
5 years
|
|||||||||||
Credit facility(a)
|
|
$
|
485
|
|
|
$
|
211
|
|
|
$
|
274
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Capital lease obligations
|
|
528
|
|
|
237
|
|
|
259
|
|
|
32
|
|
|
—
|
|
||||||
Operating leases
|
|
6,655
|
|
|
2,012
|
|
|
3,705
|
|
|
938
|
|
|
—
|
|
||||||
Unconditional purchase obligations
|
|
33,874
|
|
|
33,874
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Postretirement benefits(b)
|
|
18,066
|
|
|
313
|
|
|
655
|
|
|
688
|
|
|
16,410
|
|
||||||
Acquisition-related contingent payments(c)
|
|
3,835
|
|
|
1,278
|
|
|
2,518
|
|
|
39
|
|
|
—
|
|
||||||
Uncertain tax positions(d)
|
|
2,634
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
66,077
|
|
|
$
|
37,925
|
|
|
$
|
7,411
|
|
|
$
|
1,697
|
|
|
$
|
16,410
|
|
|
(a)
|
Amounts reflect administrative and unborrowed capacity fees under the credit facility described below.
|
||||||||||||||||||||
(b)
|
Postretirement benefit amounts represent expected payments on the accumulated postretirement benefit obligation before it is discounted.
|
||||||||||||||||||||
(c)
|
Amounts reflect the expected future earn-out payments related to the acquisitions of CLI, SBG, and Vista. These amounts also reflect the Vista employee bonus pool payments which are separate from the acquisition earn-out payments. Actual payments on these obligations may vary from the expected amounts since the total payment amount due depends upon certain future conditions. See below for further detail on the specific obligations.
|
||||||||||||||||||||
(d)
|
See below for further details on specific obligations.
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
ITEM 8.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
|
|
|
|
|
|
Index to Financial Statements
|
|
||
|
|
|
|
|
|
|
Page
|
Management's Report on Internal Control Over Financial Reporting
|
|
||
Report of Independent Registered Public Accounting Firm - Deloitte & Touche LLP
|
|
||
Report of Independent Registered Public Accounting Firm - PricewaterhouseCoopers LLP
|
|
||
Consolidated Financial Statements
|
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
Consolidated Statements of Income and Comprehensive Income
|
|
|
|
Consolidated Statements of Shareholders' Equity
|
|
|
|
Consolidated Statements of Cash Flows
|
|
|
|
Notes to Consolidated Financial Statements
|
|
|
Quarterly Information (Unaudited) - included in Item 5
|
|
||
|
|
|
|
/s/ DANIEL A. RYKHUS
|
|
/s/ STEVEN E. BRAZONES
|
Daniel A. Rykhus
|
|
Steven E. Brazones
|
President and Chief Executive Officer
|
|
Vice President and Chief Financial Officer
|
RAVEN INDUSTRIES, INC.
|
CONSOLIDATED BALANCE SHEETS
|
(Dollars and shares in thousands, except per-share amounts)
|
|
As of January 31,
|
||||||
|
2018
|
|
2017
|
||||
ASSETS
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
40,535
|
|
|
$
|
50,648
|
|
Accounts receivable, net
|
58,532
|
|
|
43,143
|
|
||
Inventories
|
55,351
|
|
|
42,336
|
|
||
Other current assets
|
5,861
|
|
|
2,689
|
|
||
Total current assets
|
160,279
|
|
|
138,816
|
|
||
|
|
|
|
||||
Property, plant and equipment, net
|
106,280
|
|
|
106,324
|
|
||
Goodwill
|
46,710
|
|
|
40,649
|
|
||
Amortizable intangible assets, net
|
10,584
|
|
|
12,048
|
|
||
Other assets
|
2,950
|
|
|
3,672
|
|
||
TOTAL ASSETS
|
$
|
326,803
|
|
|
$
|
301,509
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
||||
Current liabilities
|
|
|
|
||||
Accounts payable
|
$
|
13,106
|
|
|
$
|
8,467
|
|
Accrued liabilities
|
21,946
|
|
|
18,055
|
|
||
Other current liabilities
|
1,890
|
|
|
1,860
|
|
||
Total current liabilities
|
36,942
|
|
|
28,382
|
|
||
|
|
|
|
||||
Other liabilities
|
13,795
|
|
|
13,696
|
|
||
|
|
|
|
||||
Commitments and contingencies (see Note 12)
|
|
|
|
|
|
||
|
|
|
|
||||
Raven Industries, Inc. shareholders' equity
|
|
|
|
||||
Common stock, $1 par value, authorized shares 100,000; issued 67,124 and 67,060, respectively
|
67,124
|
|
|
67,060
|
|
||
Paid-in capital
|
59,143
|
|
|
55,795
|
|
||
Retained earnings
|
252,772
|
|
|
230,649
|
|
||
Accumulated other comprehensive loss
|
(2,573
|
)
|
|
(3,676
|
)
|
||
Less treasury stock at cost, 31,332 and 30,984 shares, respectively
|
(100,402
|
)
|
|
(90,402
|
)
|
||
Total Raven Industries, Inc. shareholders' equity
|
276,064
|
|
|
259,426
|
|
||
Noncontrolling interest
|
2
|
|
|
5
|
|
||
Total shareholders' equity
|
276,066
|
|
|
259,431
|
|
||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$
|
326,803
|
|
|
$
|
301,509
|
|
|
|
|
|
||||
The accompanying notes are an integral part of the consolidated financial statements.
|
|
|
|
RAVEN INDUSTRIES, INC.
|
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
|
(Dollars in thousands, except per-share amounts)
|
|
For the years ended January 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Net sales
|
$
|
377,317
|
|
|
$
|
277,395
|
|
|
$
|
258,229
|
|
Cost of sales
|
255,752
|
|
|
199,205
|
|
|
191,255
|
|
|||
Gross profit
|
121,565
|
|
|
78,190
|
|
|
66,974
|
|
|||
|
|
|
|
|
|
||||||
Research and development expenses
|
16,936
|
|
|
16,312
|
|
|
14,686
|
|
|||
Selling, general and administrative expenses
|
45,200
|
|
|
33,378
|
|
|
32,574
|
|
|||
Goodwill impairment loss
|
—
|
|
|
—
|
|
|
11,497
|
|
|||
Long-lived asset impairment loss
|
259
|
|
|
87
|
|
|
3,826
|
|
|||
Operating income
|
59,170
|
|
|
28,413
|
|
|
4,391
|
|
|||
|
|
|
|
|
|
||||||
Other (expense), net
|
(184
|
)
|
|
(560
|
)
|
|
(310
|
)
|
|||
Income before income taxes
|
58,986
|
|
|
27,853
|
|
|
4,081
|
|
|||
|
|
|
|
|
|
||||||
Income tax expense (benefit)
|
17,967
|
|
|
7,661
|
|
|
(767
|
)
|
|||
Net income
|
41,019
|
|
|
20,192
|
|
|
4,848
|
|
|||
|
|
|
|
|
|
||||||
Net (loss) income attributable to the noncontrolling interest
|
(3
|
)
|
|
1
|
|
|
72
|
|
|||
|
|
|
|
|
|
||||||
Net income attributable to Raven Industries, Inc.
|
$
|
41,022
|
|
|
$
|
20,191
|
|
|
$
|
4,776
|
|
|
|
|
|
|
|
||||||
Net income per common share:
|
|
|
|
|
|
||||||
─ Basic
|
$
|
1.14
|
|
|
$
|
0.56
|
|
|
$
|
0.13
|
|
─ Diluted
|
$
|
1.13
|
|
|
$
|
0.56
|
|
|
$
|
0.13
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
||||||
Comprehensive income:
|
|
|
|
|
|
||||||
Net income
|
$
|
41,019
|
|
|
$
|
20,192
|
|
|
$
|
4,848
|
|
|
|
|
|
|
|
||||||
Other comprehensive income (loss):
|
|
|
|
|
|
||||||
Foreign currency translation
|
1,234
|
|
|
50
|
|
|
(729
|
)
|
|||
Postretirement benefits, net of income tax (expense) benefit of $44, $129, and $(1,620), respectively
|
(131
|
)
|
|
(225
|
)
|
|
3,077
|
|
|||
Other comprehensive income (loss), net of tax
|
1,103
|
|
|
(175
|
)
|
|
2,348
|
|
|||
|
|
|
|
|
|
||||||
Comprehensive income
|
42,122
|
|
|
20,017
|
|
|
7,196
|
|
|||
|
|
|
|
|
|
||||||
Comprehensive (loss) income attributable to noncontrolling interest
|
(3
|
)
|
|
1
|
|
|
72
|
|
|||
|
|
|
|
|
|
||||||
Comprehensive income attributable to Raven Industries, Inc.
|
$
|
42,125
|
|
|
$
|
20,016
|
|
|
$
|
7,124
|
|
The accompanying notes are an integral part of the consolidated financial statements.
|
|
|
RAVEN INDUSTRIES, INC.
|
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
|
(Dollars and shares in thousands, except per-share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
|
$1 Par Common Stock
|
Paid-in Capital
|
Treasury Stock
|
Retained Earnings
|
Accumulated Other Comprehen-sive Income (Loss)
|
Raven Industries, Inc. Equity
|
Non-controlling Interest
|
Total Equity
|
|||||||||||||||||||
|
Shares
|
|
Cost
|
||||||||||||||||||||||||
Balance January 31, 2015
|
$
|
66,947
|
|
$
|
53,237
|
|
28,897
|
|
|
$
|
(53,362
|
)
|
$
|
244,180
|
|
$
|
(5,849
|
)
|
$
|
305,153
|
|
$
|
84
|
|
$
|
305,237
|
|
Net income
|
—
|
|
—
|
|
—
|
|
|
—
|
|
4,776
|
|
—
|
|
4,776
|
|
72
|
|
4,848
|
|
||||||||
Other comprehensive income (loss), net of income tax
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
2,348
|
|
2,348
|
|
—
|
|
2,348
|
|
||||||||
Cash dividends ($0.52 per share)
|
—
|
|
169
|
|
—
|
|
|
—
|
|
(19,513
|
)
|
—
|
|
(19,344
|
)
|
—
|
|
(19,344
|
)
|
||||||||
Dividends of less than wholly-owned subsidiary paid to noncontrolling interest
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(82
|
)
|
(82
|
)
|
||||||||
Share issuance costs related to fiscal 2015 business combination
|
—
|
|
(15
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(15
|
)
|
—
|
|
(15
|
)
|
||||||||
Shares issued on stock options exercised, net of shares withheld for employee taxes
|
7
|
|
(54
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(47
|
)
|
—
|
|
(47
|
)
|
||||||||
Shares issued on vesting of stock units, net of shares withheld for employee taxes
|
52
|
|
(510
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(458
|
)
|
—
|
|
(458
|
)
|
||||||||
Shares repurchased
|
—
|
|
—
|
|
1,603
|
|
|
(29,338
|
)
|
—
|
|
—
|
|
(29,338
|
)
|
—
|
|
(29,338
|
)
|
||||||||
Share-based compensation
|
—
|
|
2,311
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
2,311
|
|
—
|
|
2,311
|
|
||||||||
Income tax impact related to share-based compensation
|
—
|
|
(1,231
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(1,231
|
)
|
—
|
|
(1,231
|
)
|
||||||||
Balance January 31, 2016
|
67,006
|
|
53,907
|
|
30,500
|
|
|
(82,700
|
)
|
229,443
|
|
(3,501
|
)
|
264,155
|
|
74
|
|
264,229
|
|
||||||||
Net income
|
—
|
|
—
|
|
—
|
|
|
—
|
|
20,191
|
|
—
|
|
20,191
|
|
1
|
|
20,192
|
|
||||||||
Other comprehensive income, net of income tax
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
(175
|
)
|
(175
|
)
|
—
|
|
(175
|
)
|
||||||||
Cash dividends ($0.52 per share)
|
—
|
|
216
|
|
—
|
|
|
—
|
|
(18,985
|
)
|
—
|
|
(18,769
|
)
|
—
|
|
(18,769
|
)
|
||||||||
Dividends of less than wholly-owned subsidiary paid to noncontrolling interest
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(70
|
)
|
(70
|
)
|
||||||||
Director shares issued
|
19
|
|
(19
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Shares issued on vesting of stock units, net of shares withheld for employee taxes
|
35
|
|
(291
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(256
|
)
|
—
|
|
(256
|
)
|
||||||||
Shares repurchased
|
—
|
|
—
|
|
484
|
|
|
(7,702
|
)
|
—
|
|
—
|
|
(7,702
|
)
|
—
|
|
(7,702
|
)
|
||||||||
Share-based compensation
|
—
|
|
3,071
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
3,071
|
|
—
|
|
3,071
|
|
||||||||
Income tax impact related to share-based compensation
|
—
|
|
(1,089
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(1,089
|
)
|
—
|
|
(1,089
|
)
|
||||||||
Balance January 31, 2017
|
67,060
|
|
55,795
|
|
30,984
|
|
|
(90,402
|
)
|
230,649
|
|
(3,676
|
)
|
259,426
|
|
5
|
|
259,431
|
|
||||||||
Net income
|
—
|
|
—
|
|
—
|
|
|
—
|
|
41,022
|
|
—
|
|
41,022
|
|
(3
|
)
|
41,019
|
|
||||||||
Other comprehensive income, net of income tax
|
—
|
|
—
|
|
—
|
|
|
—
|
|
—
|
|
1,103
|
|
1,103
|
|
—
|
|
1,103
|
|
||||||||
Cash dividends ($0.52 per share)
|
—
|
|
214
|
|
—
|
|
|
—
|
|
(18,899
|
)
|
—
|
|
(18,685
|
)
|
—
|
|
(18,685
|
)
|
||||||||
Director shares issued
|
26
|
|
(26
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
Shares issued on stock options exercised, net of shares withheld for employee taxes
|
21
|
|
(311
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(290
|
)
|
—
|
|
(290
|
)
|
||||||||
Shares issued on vesting of stock units, net of shares withheld for employee taxes
|
17
|
|
(254
|
)
|
—
|
|
|
—
|
|
—
|
|
—
|
|
(237
|
)
|
—
|
|
(237
|
)
|
||||||||
Shares repurchased
|
—
|
|
—
|
|
348
|
|
|
(10,000
|
)
|
—
|
|
—
|
|
(10,000
|
)
|
—
|
|
(10,000
|
)
|
||||||||
Share-based compensation
|
—
|
|
3,725
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
3,725
|
|
—
|
|
3,725
|
|
||||||||
Balance January 31, 2018
|
$
|
67,124
|
|
$
|
59,143
|
|
31,332
|
|
|
$
|
(100,402
|
)
|
$
|
252,772
|
|
$
|
(2,573
|
)
|
$
|
276,064
|
|
$
|
2
|
|
$
|
276,066
|
|
The accompanying notes are an integral part of the consolidated financial statements.
|
|
|
|
|
RAVEN INDUSTRIES, INC.
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(Dollars in thousands)
|
|
For the years ended January 31,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
OPERATING ACTIVITIES:
|
|
|
|
|
|
||||||
Net income
|
$
|
41,019
|
|
|
$
|
20,192
|
|
|
$
|
4,848
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||||||
Depreciation
|
12,743
|
|
|
13,169
|
|
|
13,856
|
|
|||
Amortization of intangible assets
|
2,059
|
|
|
2,267
|
|
|
3,280
|
|
|||
Goodwill impairment loss
|
—
|
|
|
—
|
|
|
11,497
|
|
|||
Long-lived asset impairment loss
|
259
|
|
|
87
|
|
|
3,826
|
|
|||
Change in fair value of acquisition-related contingent consideration
|
457
|
|
|
36
|
|
|
(1,488
|
)
|
|||
Loss (income) from equity investments
|
114
|
|
|
72
|
|
|
(83
|
)
|
|||
Deferred income taxes
|
(787
|
)
|
|
307
|
|
|
(6,039
|
)
|
|||
Share-based compensation expense
|
3,725
|
|
|
3,071
|
|
|
2,311
|
|
|||
Other operating activities, net
|
2,053
|
|
|
2,390
|
|
|
2,112
|
|
|||
Change in operating assets and liabilities
|
(16,681
|
)
|
|
7,045
|
|
|
9,888
|
|
|||
Net cash provided by operating activities
|
44,961
|
|
|
48,636
|
|
|
44,008
|
|
|||
|
|
|
|
|
|
||||||
INVESTING ACTIVITIES:
|
|
|
|
|
|
||||||
Capital expenditures
|
(12,011
|
)
|
|
(4,796
|
)
|
|
(13,046
|
)
|
|||
Proceeds (payments) related to business acquisitions
|
(13,267
|
)
|
|
—
|
|
|
351
|
|
|||
Maturities of investments
|
250
|
|
|
250
|
|
|
250
|
|
|||
Purchases of investments
|
(273
|
)
|
|
(750
|
)
|
|
(250
|
)
|
|||
(Disbursements) proceeds from settlement of liabilities, sale of assets
|
(333
|
)
|
|
1,188
|
|
|
2,124
|
|
|||
Other investing activities, net
|
(41
|
)
|
|
(534
|
)
|
|
(503
|
)
|
|||
Net cash used in investing activities
|
(25,675
|
)
|
|
(4,642
|
)
|
|
(11,074
|
)
|
|||
|
|
|
|
|
|
||||||
FINANCING ACTIVITIES:
|
|
|
|
|
|
||||||
Dividends paid
|
(18,685
|
)
|
|
(18,839
|
)
|
|
(19,426
|
)
|
|||
Payments for common shares repurchased
|
(10,000
|
)
|
|
(7,702
|
)
|
|
(29,338
|
)
|
|||
Payment of acquisition-related contingent liabilities
|
(408
|
)
|
|
(354
|
)
|
|
(814
|
)
|
|||
Debt issuance costs paid
|
—
|
|
|
—
|
|
|
(548
|
)
|
|||
Restricted stock units vested and issued
|
(237
|
)
|
|
(256
|
)
|
|
(458
|
)
|
|||
Employee stock option exercises net of tax benefit
|
(290
|
)
|
|
—
|
|
|
(85
|
)
|
|||
Other financing activities, net
|
(101
|
)
|
|
—
|
|
|
(15
|
)
|
|||
Net cash used in financing activities
|
(29,721
|
)
|
|
(27,151
|
)
|
|
(50,684
|
)
|
|||
Effect of exchange rate changes on cash
|
322
|
|
|
23
|
|
|
(417
|
)
|
|||
Net increase (decrease) in cash and cash equivalents
|
(10,113
|
)
|
|
16,866
|
|
|
(18,167
|
)
|
|||
Cash and cash equivalents at beginning of year
|
50,648
|
|
|
33,782
|
|
|
51,949
|
|
|||
Cash and cash equivalents at end of year
|
$
|
40,535
|
|
|
$
|
50,648
|
|
|
$
|
33,782
|
|
|
|
|
|
|
|
||||||
The accompanying notes are an integral part of the consolidated financial statements.
|
|
|
|
|
|
NOTE 1
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
Building and improvements
|
15 - 39 years
|
Manufacturing equipment by segment
|
|
Applied Technology
|
3 - 5 years
|
Engineered Films
|
5 - 12 years
|
Aerostar
|
3 - 5 years
|
Furniture, fixtures, office equipment, and other
|
3 - 7 years
|
Cost of sales
|
|
Research and development (R&D) expenses
|
|
Selling, general, and administrative (SG&A)expenses
|
Direct material costs
Material acquisition and handling costs
Direct labor
Factory overhead including depreciation and amortization
Inventory obsolescence
Product warranties
Shipping and handling cost
|
|
Personnel costs
Professional service fees
Material and supplies
Facility allocation
|
|
Personnel costs
Professional service fees
Advertising
Promotions
Information technology equipment depreciation
Office supplies
Facility allocation
Bad debt expense
|
NOTE 2
|
SELECTED BALANCE SHEET INFORMATION
|
|
|
As of January 31,
|
||||||
|
|
2018(a)
|
|
2017(a)
|
||||
Accounts receivable, net:
|
|
|
|
|
||||
Trade accounts
|
|
$
|
59,510
|
|
|
$
|
43,834
|
|
Allowance for doubtful accounts
|
|
(978
|
)
|
|
(691
|
)
|
||
|
|
$
|
58,532
|
|
|
$
|
43,143
|
|
Inventories:
|
|
|
|
|
||||
Finished goods
|
|
$
|
8,054
|
|
|
$
|
5,438
|
|
In process
|
|
961
|
|
|
2,288
|
|
||
Materials
|
|
46,336
|
|
|
34,610
|
|
||
|
|
$
|
55,351
|
|
|
$
|
42,336
|
|
Other current assets:
|
|
|
|
|
||||
Insurance policy benefit
|
|
$
|
759
|
|
|
$
|
802
|
|
Federal income tax receivable
|
|
1,397
|
|
|
604
|
|
||
Prepaid expenses and other
|
|
3,705
|
|
|
1,283
|
|
||
|
|
$
|
5,861
|
|
|
$
|
2,689
|
|
Property, plant and equipment, net:
|
|
|
|
|
||||
Assets held for use and assets held for sale(a):
|
|
|
|
|
||||
Land
|
|
$
|
3,234
|
|
|
$
|
3,054
|
|
Buildings and improvements
|
|
80,299
|
|
|
77,817
|
|
||
Machinery and equipment
|
|
149,847
|
|
|
142,471
|
|
||
Accumulated depreciation
|
|
(127,523
|
)
|
|
(117,018
|
)
|
||
|
|
$
|
105,857
|
|
|
$
|
106,324
|
|
|
|
|
|
|
||||
Property, plant and equipment subject to capital leases:
|
|
|
|
|
||||
Machinery and equipment
|
|
488
|
|
|
—
|
|
||
Accumulated amortization for capitalized leases
|
|
(65
|
)
|
|
—
|
|
||
|
|
423
|
|
|
—
|
|
||
|
|
$
|
106,280
|
|
|
$
|
106,324
|
|
Other assets:
|
|
|
|
|
||||
Equity investments
|
|
$
|
1,955
|
|
|
$
|
2,371
|
|
Deferred income taxes
|
|
19
|
|
|
18
|
|
||
Other
|
|
976
|
|
|
1,283
|
|
||
|
|
$
|
2,950
|
|
|
$
|
3,672
|
|
Accrued liabilities:
|
|
|
|
|
||||
Salaries and related
|
|
$
|
9,409
|
|
|
$
|
6,286
|
|
Benefits
|
|
4,225
|
|
|
3,960
|
|
||
Insurance obligations
|
|
1,992
|
|
|
2,400
|
|
||
Warranties
|
|
1,163
|
|
|
1,547
|
|
||
Income taxes
|
|
226
|
|
|
498
|
|
||
Other taxes
|
|
1,880
|
|
|
1,540
|
|
||
Acquisition-related contingent consideration
|
|
1,036
|
|
|
445
|
|
||
Other
|
|
2,015
|
|
|
1,379
|
|
||
|
|
$
|
21,946
|
|
|
$
|
18,055
|
|
Other liabilities:
|
|
|
|
|
||||
Postretirement benefits
|
|
$
|
8,264
|
|
|
$
|
8,054
|
|
Acquisition-related contingent consideration
|
|
2,010
|
|
|
1,397
|
|
||
Deferred income taxes
|
|
615
|
|
|
1,421
|
|
||
Uncertain tax positions
|
|
2,634
|
|
|
2,610
|
|
||
Other
|
|
272
|
|
|
214
|
|
||
|
|
$
|
13,795
|
|
|
$
|
13,696
|
|
NOTE 3
|
ASSETS HELD FOR SALE
|
|
|
As of January 31
|
||
|
2018
|
|||
Assets held for sale
|
|
|
||
Property, plant and equipment, net
|
|
63
|
|
|
Goodwill
|
|
103
|
|
|
Amortizable intangible assets, net
|
|
329
|
|
|
Other assets
|
|
17
|
|
|
Total assets held for sale
|
|
$
|
512
|
|
|
|
|
||
Liabilities held for sale
|
|
|
||
Current liabilities
|
|
$
|
91
|
|
Total liabilities held for sale
|
|
$
|
91
|
|
NOTE 4
|
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
|
|
|
Cumulative foreign currency translation adjustment
|
|
Postretirement benefits
|
|
Total
|
||||||
Balance at January 31, 2016
|
|
$
|
(2,477
|
)
|
|
$
|
(1,024
|
)
|
|
$
|
(3,501
|
)
|
Other comprehensive income (loss) before reclassifications
|
|
50
|
|
|
—
|
|
|
50
|
|
|||
Amounts reclassified from accumulated other comprehensive (loss) after tax benefit of $129
|
|
—
|
|
|
(225
|
)
|
|
(225
|
)
|
|||
Balance at January 31, 2017
|
|
(2,427
|
)
|
|
(1,249
|
)
|
|
(3,676
|
)
|
|||
Other comprehensive income before reclassifications
|
|
1,234
|
|
|
—
|
|
|
1,234
|
|
|||
Amounts reclassified from accumulated other comprehensive (loss) after tax benefit of $44
|
|
—
|
|
|
(131
|
)
|
|
(131
|
)
|
|||
Balance at January 31, 2018
|
|
$
|
(1,193
|
)
|
|
$
|
(1,380
|
)
|
|
$
|
(2,573
|
)
|
NOTE 5
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
||||||
Accounts receivable
|
|
$
|
(7,014
|
)
|
|
$
|
(5,361
|
)
|
|
$
|
16,847
|
|
Inventories
|
|
(11,062
|
)
|
|
1,215
|
|
|
7,564
|
|
|||
Prepaid expenses and other assets
|
|
(2,445
|
)
|
|
228
|
|
|
(111
|
)
|
|||
Accounts payable
|
|
1,280
|
|
|
2,558
|
|
|
(5,059
|
)
|
|||
Accrued and other liabilities
|
|
2,560
|
|
|
8,405
|
|
|
(9,353
|
)
|
|||
|
|
$
|
(16,681
|
)
|
|
$
|
7,045
|
|
|
$
|
9,888
|
|
|
|
|
|
|
|
|
||||||
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
||||||
Cash paid during the year for income taxes
|
|
$
|
19,854
|
|
|
$
|
6,618
|
|
|
$
|
6,558
|
|
Interest paid
|
|
$
|
186
|
|
|
$
|
190
|
|
|
$
|
129
|
|
|
|
|
|
|
|
|
||||||
Significant non-cash transactions:
|
|
|
|
|
|
|
||||||
Capital expenditures included in accounts payable
|
|
$
|
418
|
|
|
$
|
84
|
|
|
$
|
161
|
|
Assets acquired under capital leases
|
|
$
|
79
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Capital expenditures converted from inventory
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,036
|
|
NOTE 6
|
ACQUISITIONS OF AND INVESTMENTS IN BUSINESSES AND TECHNOLOGIES
|
|
|
For the years ended January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Beginning balance
|
|
$
|
1,741
|
|
|
$
|
2,059
|
|
Fair value of contingent consideration acquired
|
|
1,256
|
|
|
—
|
|
||
Change in fair value of the liability
|
|
457
|
|
|
36
|
|
||
Contingent consideration earn-out paid
|
|
(408
|
)
|
|
(354
|
)
|
||
Ending balance
|
|
$
|
3,046
|
|
|
$
|
1,741
|
|
|
|
|
|
|
||||
Classification of liability in the Consolidated balance sheet
|
|
|
|
|
||||
Accrued Liabilities
|
|
$
|
1,036
|
|
|
$
|
345
|
|
Other Liabilities, long-term
|
|
2,010
|
|
|
1,396
|
|
||
Balance at January 31, 2018
|
|
$
|
3,046
|
|
|
$
|
1,741
|
|
|
|
As of January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Balance at beginning of year
|
|
$
|
2,371
|
|
|
$
|
2,805
|
|
Purchase price of equity investment
|
|
—
|
|
|
135
|
|
||
(Loss) income from equity investment
|
|
(42
|
)
|
|
(72
|
)
|
||
Amortization of intangible assets
|
|
(320
|
)
|
|
(497
|
)
|
||
Impairment to equity investment
|
|
(72
|
)
|
|
—
|
|
||
Balance at end of year
|
|
$
|
1,937
|
|
|
$
|
2,371
|
|
NOTE 7
|
GOODWILL, LONG-LIVED ASSETS, AND OTHER CHARGES
|
|
|
Applied
Technology
|
|
Engineered
Films
|
|
Aerostar
|
|
Total
|
||||||||
Balance at January 31, 2016
|
|
$
|
12,365
|
|
|
$
|
27,518
|
|
|
$
|
789
|
|
|
$
|
40,672
|
|
Foreign currency translation adjustment
|
|
(23
|
)
|
|
—
|
|
|
—
|
|
|
(23
|
)
|
||||
Reporting unit transfer balance(a)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Balance at January 31, 2017
|
|
12,342
|
|
|
27,518
|
|
|
789
|
|
|
40,649
|
|
||||
Additions due to business combinations
|
|
—
|
|
|
5,714
|
|
|
—
|
|
|
5,714
|
|
||||
Divestiture of business
|
|
—
|
|
|
—
|
|
|
(52
|
)
|
|
(52
|
)
|
||||
Foreign currency translation adjustment
|
|
399
|
|
|
—
|
|
|
—
|
|
|
399
|
|
||||
Balance at January 31, 2018
|
|
$
|
12,741
|
|
|
$
|
33,232
|
|
|
$
|
737
|
|
|
$
|
46,710
|
|
|
|
As of January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Gross goodwill
|
|
$
|
58,207
|
|
|
$
|
52,146
|
|
Accumulated impairment loss
|
|
(11,497
|
)
|
|
(11,497
|
)
|
||
Net goodwill
|
|
$
|
46,710
|
|
|
$
|
40,649
|
|
|
|
For the years ended January 31,
|
||||||||||||||||||
|
|
2018
|
|
2017
|
||||||||||||||||
|
|
|
Accumulated
|
|
|
|
Accumulated
|
|
||||||||||||
|
|
Amount
|
amortization
|
Net
|
|
Amount
|
amortization
|
Net
|
||||||||||||
Existing technology
|
|
$
|
7,290
|
|
$
|
(6,996
|
)
|
$
|
294
|
|
|
$
|
7,136
|
|
$
|
(6,553
|
)
|
$
|
583
|
|
Customer relationships
|
|
13,264
|
|
(4,834
|
)
|
8,430
|
|
|
12,987
|
|
(3,680
|
)
|
9,307
|
|
||||||
Patents and other intangibles
|
|
4,241
|
|
(2,381
|
)
|
1,860
|
|
|
4,378
|
|
(2,220
|
)
|
2,158
|
|
||||||
Total
|
|
$
|
24,795
|
|
$
|
(14,211
|
)
|
$
|
10,584
|
|
|
$
|
24,501
|
|
$
|
(12,453
|
)
|
$
|
12,048
|
|
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
||||||||||
Estimated amortization expense
|
|
$
|
1,988
|
|
|
$
|
1,578
|
|
|
$
|
1,163
|
|
|
$
|
1,111
|
|
|
$
|
1,013
|
|
NOTE 8
|
EMPLOYEE POSTRETIREMENT BENEFITS
|
|
|
For the years ended January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Benefit obligation at beginning of year
|
|
$
|
8,416
|
|
|
$
|
7,991
|
|
Service cost
|
|
74
|
|
|
80
|
|
||
Interest cost
|
|
312
|
|
|
333
|
|
||
Actuarial loss (gain) and assumption changes
|
|
112
|
|
|
341
|
|
||
Retiree benefits paid
|
|
(343
|
)
|
|
(329
|
)
|
||
Benefit obligation at end of year
|
|
$
|
8,571
|
|
|
$
|
8,416
|
|
|
|
For the years ended January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Amounts not yet recognized in net periodic benefit cost:
|
|
|
|
|
||||
Net actuarial loss
|
|
$
|
2,714
|
|
|
$
|
2,699
|
|
Prior service cost
|
|
(572
|
)
|
|
(732
|
)
|
||
Total pre-tax accumulated other comprehensive loss
|
|
$
|
2,142
|
|
|
$
|
1,967
|
|
|
|
|
|
|
||||
Pre-tax accumulated other comprehensive loss - beginning of year related to benefit obligation
|
|
$
|
1,967
|
|
|
$
|
1,612
|
|
Reclassification adjustments recognized in benefit cost:
|
|
|
|
|
||||
Recognized net (loss)
|
|
(96
|
)
|
|
(146
|
)
|
||
Amortization of prior service cost
|
|
159
|
|
|
160
|
|
||
Amounts recognized in AOCI during the year:
|
|
|
|
|
||||
Net actuarial loss (gain)
|
|
112
|
|
|
341
|
|
||
Pre-tax accumulated other comprehensive loss - end of year related to benefit obligation
|
|
$
|
2,142
|
|
|
$
|
1,967
|
|
|
|
For the years ended January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Beginning liability balance
|
|
$
|
8,416
|
|
|
$
|
7,991
|
|
Net periodic benefit cost
|
|
323
|
|
|
399
|
|
||
Other comprehensive loss
|
|
175
|
|
|
355
|
|
||
Total recognized in net periodic benefit cost and other comprehensive income
|
|
498
|
|
|
754
|
|
||
Retiree benefits paid
|
|
(343
|
)
|
|
(329
|
)
|
||
Ending liability balance
|
|
$
|
8,571
|
|
|
$
|
8,416
|
|
|
|
|
|
|
||||
Current portion in accrued liabilities
|
|
$
|
307
|
|
|
$
|
362
|
|
Long-term portion in other liabilities
|
|
$
|
8,264
|
|
|
$
|
8,054
|
|
|
|
|
|
|
||||
Assumptions used to calculate benefit obligation:
|
|
|
|
|
||||
Discount rate
|
|
3.75
|
%
|
|
4.00
|
%
|
||
Rate of compensation increase
|
|
4.00
|
%
|
|
4.00
|
%
|
||
Health care cost trend rates:
|
|
|
|
|
||||
Health care cost trend rate assumed for next year
|
|
6.50
|
%
|
|
6.67
|
%
|
||
Ultimate health care cost trend rate
|
|
4.50
|
%
|
|
4.50
|
%
|
||
Year that the rate reaches the ultimate trend rate
|
|
2030
|
|
|
2030
|
|
||
Assumptions used to calculated the net periodic benefit cost:
|
|
|
|
|
||||
Discount rate
|
|
4.00
|
%
|
|
4.25
|
%
|
||
Rate of compensation increase
|
|
4.00
|
%
|
|
4.00
|
%
|
|
|
January 31, 2018
|
||||||
|
|
One-percentage-point increase
|
|
One-percentage-point decrease
|
||||
Effect on total of service and interest cost components
|
|
$
|
71
|
|
|
$
|
(58
|
)
|
Effect on accumulated postretirement benefit obligation
|
|
$
|
1,180
|
|
|
$
|
(1,045
|
)
|
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023 - 2028
|
||||||||||
Expected postretirement medical and other benefit payments
|
|
$
|
313
|
|
|
$
|
323
|
|
|
$
|
332
|
|
|
$
|
341
|
|
|
$
|
2,192
|
|
NOTE 9
|
WARRANTIES
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Beginning balance
|
|
$
|
1,547
|
|
|
$
|
1,835
|
|
|
$
|
3,120
|
|
Change in provision
|
|
1,762
|
|
|
1,597
|
|
|
1,945
|
|
|||
Settlements made
|
|
(2,146
|
)
|
|
(1,885
|
)
|
|
(3,230
|
)
|
|||
Ending balance
|
|
$
|
1,163
|
|
|
$
|
1,547
|
|
|
$
|
1,835
|
|
NOTE 10
|
INCOME TAXES
|
|
|
For the years ended January 31,
|
|||||||
|
|
2018
|
|
2017
|
|
2016
|
|||
Tax at U.S. federal statutory rate
|
|
33.8
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
Impact of the Tax Cuts and Jobs Act
|
|
(0.1
|
)
|
|
—
|
|
|
—
|
|
State and local income taxes, net of U.S. federal tax benefit
|
|
1.6
|
|
|
0.7
|
|
|
(2.8
|
)
|
Tax credit for research activities
|
|
(1.8
|
)
|
|
(3.7
|
)
|
|
(24.2
|
)
|
Tax benefit on qualified production activities
|
|
(3.0
|
)
|
|
(2.8
|
)
|
|
(13.7
|
)
|
Tax benefit on insurance premiums
|
|
(1.3
|
)
|
|
(1.5
|
)
|
|
(10.3
|
)
|
Change in uncertain tax positions
|
|
0.1
|
|
|
(0.3
|
)
|
|
1.8
|
|
Foreign tax rate difference
|
|
—
|
|
|
(0.3
|
)
|
|
(2.9
|
)
|
Impact of settlement of stock-based awards
|
|
1.2
|
|
|
—
|
|
|
—
|
|
Other, net
|
|
—
|
|
|
0.4
|
|
|
(1.7
|
)
|
|
|
30.5
|
%
|
|
27.5
|
%
|
|
(18.8
|
)%
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Income tax provision:
|
|
|
|
|
|
|
||||||
Currently payable
|
|
$
|
18,754
|
|
|
$
|
7,354
|
|
|
$
|
5,272
|
|
Deferred expense (benefit)
|
|
(787
|
)
|
|
307
|
|
|
(6,039
|
)
|
|||
Income tax expense (benefit)
|
|
$
|
17,967
|
|
|
$
|
7,661
|
|
|
$
|
(767
|
)
|
|
|
As of January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Deferred tax assets:
|
|
|
|
|
||||
Accounts receivable
|
|
$
|
184
|
|
|
$
|
212
|
|
Inventories
|
|
664
|
|
|
978
|
|
||
Accrued vacation
|
|
647
|
|
|
887
|
|
||
Insurance obligations
|
|
137
|
|
|
383
|
|
||
Accrued benefit liabilities
|
|
—
|
|
|
41
|
|
||
Warranty obligations
|
|
262
|
|
|
565
|
|
||
Postretirement benefits
|
|
1,929
|
|
|
3,072
|
|
||
Uncertain tax positions
|
|
491
|
|
|
803
|
|
||
Share-based compensation
|
|
1,761
|
|
|
3,201
|
|
||
Other accrued liabilities
|
|
54
|
|
|
68
|
|
||
|
|
6,129
|
|
|
10,210
|
|
||
|
|
|
|
|
||||
Deferred tax (liabilities):
|
|
|
|
|
||||
Depreciation and amortization
|
|
(6,082
|
)
|
|
(10,565
|
)
|
||
Other
|
|
(643
|
)
|
|
(1,048
|
)
|
||
|
|
(6,725
|
)
|
|
(11,613
|
)
|
||
Net deferred tax (liability)
|
|
$
|
(596
|
)
|
|
$
|
(1,403
|
)
|
|
|
For the years ended January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Gross unrecognized tax benefits at beginning of year
|
|
$
|
2,110
|
|
|
$
|
2,327
|
|
Increases in tax positions related to the current year
|
|
426
|
|
|
279
|
|
||
Decreases in tax positions related to prior years
|
|
—
|
|
|
(193
|
)
|
||
Decreases as a result of lapses in applicable statutes of limitation
|
|
(320
|
)
|
|
(303
|
)
|
||
Gross unrecognized tax benefits at end of year
|
|
$
|
2,216
|
|
|
$
|
2,110
|
|
NOTE 11
|
FINANCING ARRANGEMENTS
|
|
|
As of January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Unamortized debt issuance costs(a)
|
|
$
|
242
|
|
|
$
|
352
|
|
|
|
As of January 31,
|
||||||
|
|
2018
|
|
2017
|
||||
Letters of credit outstanding (a)
|
|
$
|
1,097
|
|
|
$
|
514
|
|
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
||||||||||||
Minimum lease payments
|
|
$
|
2,012
|
|
|
$
|
1,925
|
|
|
$
|
1,780
|
|
|
$
|
501
|
|
|
$
|
437
|
|
|
$
|
—
|
|
NOTE 12
|
COMMITMENTS AND CONTINGENCIES
|
NOTE 13
|
RESTRUCTURING COSTS
|
NOTE 14
|
SHARE-BASED COMPENSATION
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Share-based compensation cost
|
|
$
|
3,725
|
|
|
$
|
3,071
|
|
|
$
|
2,311
|
|
Tax benefit
|
|
1,275
|
|
|
1,103
|
|
|
819
|
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Risk-free interest rate
|
|
1.68
|
%
|
|
1.05
|
%
|
|
1.33
|
%
|
|||
Expected dividend yield
|
|
1.78
|
%
|
|
3.33
|
%
|
|
2.59
|
%
|
|||
Expected volatility factor
|
|
33.87
|
%
|
|
32.61
|
%
|
|
36.81
|
%
|
|||
Expected option term (in years)
|
|
4.25
|
|
|
4.00
|
|
|
3.75
|
|
|||
|
|
|
|
|
|
|
||||||
Weighted average grant date fair value
|
|
$
|
7.35
|
|
|
$
|
3.05
|
|
|
$
|
4.77
|
|
|
|
Number
of options |
|
Weighted average exercise price
|
|
Aggregate intrinsic value
|
|
Weighted
average remaining contractual term (years) |
|||||
Outstanding, January 31, 2017
|
|
990,900
|
|
|
$
|
24.58
|
|
|
|
|
|
||
Granted
|
|
85,800
|
|
|
29.20
|
|
|
|
|
|
|||
Exercised
|
|
(206,000
|
)
|
|
31.01
|
|
|
|
|
|
|||
Forfeited
|
|
(43,600
|
)
|
|
19.05
|
|
|
|
|
|
|||
Expired
|
|
(124,150
|
)
|
|
31.70
|
|
|
|
|
|
|||
Outstanding, January 31, 2018
|
|
702,950
|
|
|
$
|
22.34
|
|
|
$
|
11,396
|
|
|
2.49
|
|
|
|
|
|
|
|
|
|
|||||
Outstanding exercisable, January 31, 2018
|
|
331,717
|
|
|
$
|
23.43
|
|
|
$
|
5,014
|
|
|
1.95
|
|
|
|
|
|
|
|
|
|
|||||
Options vested, or expected to vest, January 31, 2018
|
|
702,950
|
|
|
$
|
22.34
|
|
|
$
|
11,396
|
|
|
2.49
|
|
|
Number
of restricted stock units |
|
Weighted
average grant date fair value per share |
|||
Outstanding, January 31, 2017
|
|
126,729
|
|
|
$
|
19.19
|
|
Granted
|
|
61,270
|
|
|
29.33
|
|
|
Vested
|
|
(23,122
|
)
|
|
29.62
|
|
|
Forfeited
|
|
(18,028
|
)
|
|
18.92
|
|
|
Outstanding, January 31, 2018
|
|
146,849
|
|
|
$
|
21.81
|
|
|
|
|
|
|
|||
Cumulative dividends, January 31, 2018
|
|
5,129
|
|
|
|
|
|
Number
of restricted stock units expected to vest |
|
Weighted
average grant date fair value per share |
|||
Outstanding, January 31, 2017
|
|
146,519
|
|
|
$
|
16.78
|
|
Granted
|
|
22,745
|
|
|
29.20
|
|
|
Vested
|
|
—
|
|
|
—
|
|
|
Forfeited
|
|
(16,164
|
)
|
|
16.89
|
|
|
Performance-based adjustment
|
|
26,629
|
|
|
23.96
|
|
|
Outstanding, January 31, 2018
|
|
179,729
|
|
|
$
|
19.40
|
|
|
|
|
|
|
|||
Cumulative dividends, January 31, 2018
|
|
7,130
|
|
|
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Weighted average grant date fair value: time-based RSUs
|
|
$
|
29.33
|
|
|
$
|
15.94
|
|
|
$
|
19.25
|
|
Weighted average grant date fair value: performance-based RSUs
|
|
$
|
29.20
|
|
|
$
|
15.61
|
|
|
$
|
20.09
|
|
|
|
Number
of stock units |
|
Weighted
average price |
|||
Outstanding, January 31, 2017
|
|
98,649
|
|
|
$
|
20.82
|
|
Granted
|
|
12,000
|
|
|
35.00
|
|
|
Deferred retainers
|
|
1,143
|
|
|
35.00
|
|
|
Dividends
|
|
1,547
|
|
|
33.98
|
|
|
Converted into common shares
|
|
(25,725
|
)
|
|
33.88
|
|
|
Outstanding, January 31, 2018
|
|
87,614
|
|
|
$
|
19.35
|
|
NOTE 15
|
NET INCOME PER SHARE
|
|
|
For the years ended January 31,
|
|||||||
|
|
2018
|
|
2017
|
|
2016
|
|||
Anti-dilutive options and restricted stock units
|
|
344,774
|
|
|
884,099
|
|
|
1,107,733
|
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Numerator:
|
|
|
|
|
|
|
||||||
Net income attributable to Raven Industries, Inc.
|
|
$
|
41,022
|
|
|
$
|
20,191
|
|
|
$
|
4,776
|
|
|
|
|
|
|
|
|
||||||
Denominator:
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding
|
|
35,945,225
|
|
|
36,142,416
|
|
|
37,237,717
|
|
|||
Weighted average stock units outstanding
|
|
104,980
|
|
|
100,019
|
|
|
86,745
|
|
|||
Denominator for basic calculation
|
|
36,050,205
|
|
|
36,242,435
|
|
|
37,324,462
|
|
|||
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding
|
|
35,945,225
|
|
|
36,142,416
|
|
|
37,237,717
|
|
|||
Weighted average stock units outstanding
|
|
104,980
|
|
|
100,019
|
|
|
86,745
|
|
|||
Dilutive impact of stock options and RSUs
|
|
399,620
|
|
|
129,480
|
|
|
75,481
|
|
|||
Denominator for diluted calculation
|
|
36,449,825
|
|
|
36,371,915
|
|
|
37,399,943
|
|
|||
|
|
|
|
|
|
|
||||||
Net income per share - basic
|
|
$
|
1.14
|
|
|
$
|
0.56
|
|
|
$
|
0.13
|
|
Net income per share - diluted
|
|
$
|
1.13
|
|
|
$
|
0.56
|
|
|
$
|
0.13
|
|
NOTE 16
|
BUSINESS SEGMENTS AND MAJOR CUSTOMER INFORMATION
|
|
|
For the years ended January 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
Canada
|
|
$
|
12,940
|
|
|
$
|
13,969
|
|
|
$
|
11,789
|
|
Europe
|
|
13,864
|
|
|
13,924
|
|
|
10,526
|
|
|||
Latin America
|
|
4,439
|
|
|
3,402
|
|
|
2,676
|
|
|||
Asia
|
|
4,074
|
|
|
1,535
|
|
|
482
|
|
|||
Other foreign sales
|
|
6,239
|
|
|
2,698
|
|
|
2,376
|
|
|||
Total foreign sales
|
|
41,556
|
|
|
35,528
|
|
|
27,849
|
|
|||
United States
|
|
335,761
|
|
|
241,867
|
|
|
230,380
|
|
|||
|
|
$
|
377,317
|
|
|
$
|
277,395
|
|
|
$
|
258,229
|
|
NOTE 17
|
SUBSEQUENT EVENTS
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
ITEM 9B.
|
OTHER INFORMATION
|
ITEM 16.
|
FORM 10-K SUMMARY
|
Exhibit
Number
|
|
Description
|
|
|
|
|
Asset Purchase Agreement by and among Colorado Lining International, Inc., John B. Heap, Patrick Elliott, and Raven Industries, Inc., dated as of August 22, 2017 (incorporated herein by reference to Exhibit 2.1 of the Company's Form 10-Q filed November 21, 2017.
|
|
|
|
|
3(a)
|
|
Articles of Incorporation of Raven Industries, Inc. and all amendments thereto (incorporated herein by reference to the corresponding exhibit of the Company's Form 10-K for the year ended January 31, 1989). ‡
|
|
|
|
|
Amended and Restated Bylaws of Raven Industries, Inc. (incorporated herein by reference to Exhibit B of the Company's definitive Proxy Statement filed April 12, 2012).
|
|
|
|
|
|
Amended and Restated 2010 Stock Incentive Plan adopted May 25, 2017 (incorporated herein by reference to Exhibit A of the Company’s definitive Proxy Statement filed April 19, 2017). †
|
|
|
|
|
|
Form of Non-Qualified Stock Option Agreement (incorporated herein by reference to Exhibit 10(r) of the Company's Form 10-Q filed June 4, 2012). †
|
|
|
|
|
|
Form of Restricted Stock Unit Agreement (incorporated herein by reference to Exhibit 10(s) of the Company's Form 10-Q filed June 4, 2012). †
|
|
|
|
|
|
Raven Industries, Inc. Non-Qualified Deferred Compensation Plan, effective as of January 1, 2018 and filed herewith as Exhibit 10.1. †
|
|
|
|
|
|
Raven Industries, Inc. Deferred Compensation Plan for Directors adopted May 23, 2007 (incorporated herein by reference to Exhibit 10.1 of the Company's Form8-K filed May 24, 2006). †
|
|
|
|
|
|
Credit Agreement, dated April 15, 2015, by and among Raven Industries, Inc. and JPMorgan Chase Bank, N.A., Toronto Branch, as Canadian Administrative Agent, JPMorgan Chase Bank National Association, as Administrative Agent, and JP Morgan Securities LLC and Wells Fargo Securities, LLC as Joint Bookrunners and Joint Lead Arrangers (incorporated herein by reference to Exhibit 10.1 of the Company's Form 8-K filed April 16, 2015).
|
|
|
|
|
|
Guaranty, dated as of April 15, 2015, made by each of the Guarantors (Raven Industries, Inc., Aerostar International, Inc., Vista Research, Inc., and Integra Plastics, Inc.) in favor of JPMorgan Chase Bank, N.A. as Administrative Agent on behalf of the guaranteed parties (incorporated herein by reference to Exhibit 10.2 of the Company's Form 8-K filed April 16, 2015).
|
|
|
|
|
|
Amended and Restated Employment Agreement between Raven Industries, Inc. and Daniel A. Rykhus dated as of March 29, 2017 (incorporated herein by reference to Exhibit 10.1 of the Company's Form 10-K filed March 31, 2017). †
|
|
|
|
|
|
Amended and Restated Employment Agreement between Raven Industries, Inc. and Steven E. Brazones dated as of March 29, 2017 (incorporated herein by reference to Exhibit 10.2 of the Company's Form 10-K filed March 31, 2017). †
|
|
|
|
|
|
Form of Amended and Restated Change in Control Agreement between Raven Industries, Inc. and the following senior executive officers: Anthony D. Schmidt, Brian E. Meyer, and Janet L. Matthiesen dated as of March 28, 2016 (incorporated herein by reference to Exhibit 10.1 of the Company's Form 10-K filed March 29, 2016). †
|
|
|
|
|
|
Form of Amended Employment Agreement between Raven Industries, Inc. and the following senior executive officers: Brian E. Meyer and Janet L. Matthiesen dated August 25, 2015 (incorporated herein by reference to Exhibit 10.1 of the Company's Form 8-K filed August 31, 2015). †
|
|
|
|
|
|
Employment Agreement between Raven Industries, Inc. and Anthony D. Schmidt dated as of February 1, 2012 (incorporated herein by reference to Exhibit 10.1 of the Company's Form 8-K filed February 1, 2012). †
|
|
|
|
|
|
Form of Schedule A to Employment Agreement, revised effective January 1, 2016, between Raven Industries, Inc. and the following senior executive officers: Janet L. Matthiesen, Brian E. Meyer, and Anthony D. Schmidt (incorporated herein by reference to Exhibit 10.3 of the Company's Form 10-K filed March 31, 2017). †
|
|
|
|
|
|
Letter of PricewaterhouseCoopers LLP to the Securities and Exchange Commission, dated as of April 6, 2017, (incorporated herein by reference to Exhibit 16.1 of the Company's Form 8-K filed April 6, 2017).
|
|
|
|
|
|
Subsidiaries of the Registrant.
|
|
|
|
|
|
Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm.
|
|
|
|
|
|
Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.
|
|
|
|
|
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
101.INS
|
|
Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
†
|
|
Management contract or compensatory plan or arrangement.
|
‡
|
|
Filed in paper.
|
SIGNATURES
|
|||
|
|
|
|
SIGNATURES
|
|
|
|
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|||
|
|
|
|
RAVEN INDUSTRIES, INC.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
By: /s/ DANIEL A. RYKHUS
|
|
|
|
Daniel A. Rykhus
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
|
|
Date: March 23, 2018
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
|
||
|
|
|
/s/ DANIEL A. RYKHUS
|
|
|
Daniel A. Rykhus
|
|
|
President and Chief Executive Officer
|
|
|
(principal executive officer) and Director
|
|
|
|
|
|
|
|
|
/s/ STEVEN E. BRAZONES
|
|
/s/ THOMAS S. EVERIST
|
Steven E. Brazones
|
|
Thomas S. Everist
|
Vice President and Chief Financial Officer
|
|
Director
|
(principal financial and accounting officer)
|
|
|
|
|
|
|
|
|
/s/ MARC E. LEBARON
|
|
/s/ KEVIN T. KIRBY
|
Marc E. LeBaron
|
|
Kevin T. Kirby
|
Chairman of the Board
|
|
Director
|
|
|
|
|
|
|
/s/ JASON M. ANDRINGA
|
|
/s/ RICHARD W. PAROD
|
Jason M. Andringa
|
|
Richard W. Parod
|
Director
|
|
Director
|
|
|
|
|
|
|
/s/ DAVID L. CHICOINE
|
|
|
David L. Chicoine
|
|
|
Director
|
|
|
|
|
|
|
|
|
|
|
Date: March 23, 2018
|
Column A
|
Column B
|
Column C
|
Column D
|
Column E
|
|||||||||||
|
|
Additions
|
|
|
|||||||||||
Description
|
Balance at
Beginning
of Year
|
Charged to
Costs and
Expenses
|
Charged to
Other
Accounts
|
Deductions
From
Reserves (1)
|
Balance at
End of Year
|
||||||||||
Deducted in the balance sheet from the asset to which it applies:
|
|
|
|
|
|
||||||||||
Allowance for doubtful accounts:
|
|
|
|
|
|
||||||||||
Year ended January 31, 2018
|
$
|
691
|
|
$
|
357
|
|
$
|
—
|
|
$
|
70
|
|
$
|
978
|
|
Year ended January 31, 2017
|
1,034
|
|
380
|
|
—
|
|
723
|
|
691
|
|
|||||
Year ended January 31, 2016
|
319
|
|
1,066
|
|
—
|
|
351
|
|
1,034
|
|
(1)
|
Represents uncollectable accounts receivable written off during the year, net of recoveries.
|
|
|
By:
|
/s/ Janet L. Matthiesen
|
Name:
|
Janet L. Matthiesen
|
Title:
|
Vice President of Human Resources
|
|
|
Date:
|
November 7, 2017
|
RAVEN INDUSTRIES, INC.
|
||
SUBSIDIARIES OF THE REGISTRANT
|
||
|
|
|
NAME OF SUBSIDIARY
|
|
JURISDICTION
|
|
|
|
Aerostar Integrated Systems, LLC (a)
|
|
Delaware, USA
|
|
|
|
Aerostar International, Inc.
|
|
South Dakota, USA
|
|
|
|
Raven Industries Canada, Inc.
|
|
Nova Scotia, Canada
|
|
|
|
Raven International Holding Company B.V.
|
|
Amsterdam, Netherlands
|
|
|
|
SBG Innovatie BV
|
|
Middenmeer, Netherlands
|
|
|
|
Vista Research, Inc.
|
|
California, USA
|
|
|
|
|
|
|
(a) 75% owned
|
|
|
1.
|
I have reviewed this Annual Report on Form 10-K of Raven Industries, Inc. (the Registrant);
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and
|
5.
|
The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of Registrant's board of directors (or others performing the equivalent function):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal controls over financial reporting.
|
Dated: March 23, 2018
|
/s/ DANIEL A. RYKHUS
|
|
Daniel A. Rykhus
|
|
President and Chief Executive Officer
|
1.
|
I have reviewed this Annual Report on Form 10-K of Raven Industries, Inc. (the Registrant);
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
|
4.
|
The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and
|
5.
|
The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of Registrant's board of directors (or others performing the equivalent function):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal controls over financial reporting.
|
Dated: March 23, 2018
|
/s/ STEVEN E. BRAZONES
|
|
Steven E. Brazones
|
|
Vice President and Chief Financial Officer
|
•
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
•
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Raven Industries, Inc.
|
Dated: March 23, 2018
|
/s/ DANIEL A. RYKHUS
|
|
Daniel A. Rykhus
|
|
President and Chief Executive Officer
|
•
|
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
•
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Raven Industries, Inc.
|
Dated: March 23, 2018
|
/s/ STEVEN E. BRAZONES
|
|
Steven E. Brazones
|
|
Vice President and Chief Financial Officer
|
|
|